| Identification | Back Directory | [Name]
3-chloro-4-(6-hydroxyquinolin-2-yl)benzoic acid | [CAS]
1371587-51-7 | [Synonyms]
3-chloro-4-(6-hydroxyquinolin-2-yl)benzoic acid
Benzoic acid, 3-chloro-4-(6-hydroxy-2-quinolinyl)- | [Molecular Formula]
C16H10ClNO3 | [MDL Number]
MFCD30489304 | [MOL File]
1371587-51-7.mol | [Molecular Weight]
299.71 |
| Chemical Properties | Back Directory | [Boiling point ]
527.5±50.0 °C(Predicted) | [density ]
1.462±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [form ]
Solid | [pka]
2.70±0.10(Predicted) | [color ]
Light yellow to yellow |
| Hazard Information | Back Directory | [Uses]
Cavosonstat (N91115) is an orally active S-nitrosoglutathione reductase (GSNOR) inhibitor. Cavosonstat is a CFTR stabilizer, and can be used for cystic fibrosis research[1]. | [References]
[1] Scott H Donaldson, et al. Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508DEL-CFTR. J Cyst Fibros. 2017 May;16(3):371-379. DOI:10.1016/j.jcf.2017.01.009 |
|
|